12/16
10:49 am
nrsn
NeuroSense Therapeutics Ltd. (NASDAQ: NRSN) had its "hold" rating re-affirmed by analysts at Maxim Group.
Medium
Report
NeuroSense Therapeutics Ltd. (NASDAQ: NRSN) had its "hold" rating re-affirmed by analysts at Maxim Group.
12/16
10:26 am
nrsn
Rating for NRSN
Medium
Report
Rating for NRSN
12/16
07:35 am
nrsn
NeuroSense downgraded to Hold from Buy at Maxim
Low
Report
NeuroSense downgraded to Hold from Buy at Maxim